Table 1.
Patient and tumor characteristics
| Patient and Tumor Characteristics | Training Set | Testing Set | ||||
|---|---|---|---|---|---|---|
| Cases | BPM† | P-value‡ | Cases | BPM† | P-value‡ | |
| Number of Subjects, N | 101 | 134 | 118 | 56 | ||
| Age, average (min-max) | 59 (23–85) | 57 (30–83) | 0.14 | 61 (36–86) | 55 (33–79) | 0.009 |
| Menopausal Status, N (%) | ||||||
| Pre | 21 (20.8%) | 39 (29.1%) | 0.17 | 19 (16.1%) | 18 (32.1%) | 0.02 |
| Post | 80 (79.2%) | 95 (70.9%) | 99 (83.8%) | 38 (67.8%) | ||
| Race, N (%) | ||||||
| White | 83 (82.2%) | 104 (77.6%) | 0.18 | 87 (73.7%) | 42 (75%) | 0.52 |
| Black | 5 (5%) | 3 (2.2%) | 9 (7.6%) | 9 (16.1%) | ||
| Asian | 2 (2%) | 3 (2.2%) | 13 (11%) | 1 (1.8%) | ||
| American Indian | - | 1 (0.7%) | - | - | ||
| Pacific Islander | - | - | 9 (7.6%) | 4 (7.1%) | ||
| Unknown | 11 (10.9%) | 23 (17.2%) | - | - | ||
| Stage, N (%) | ||||||
| Stage I and II | 39 (38.6%) | - | 20 (16.9%) | - | ||
| Stage III and IV | 62 (61.4%) | - | 98 (83.1%) | - | ||
| Histological Subtype, N (%) | ||||||
| Serous | 69 (68.3%) | - | 114 (96.6%) | - | ||
| Non-Serous | 32 (31.7%) | - | 1 (0.8%) | - | ||
| Unknown | 3 (2.54%) | |||||
| ROMA, median (25th/75th Percentiles) | 86.85 (36.85–98.03) | 11.14 (6.64–20.66) | <0.0001 | 89.51 (70.55–96.95) | 13.66 (6.42–18.56) | <0.0001 |
†
individuals with benign pelvic masses (BPM)
‡
Statistical significance was determined by Wilcoxon rank sum tests for continuous variables and Fisher’s exact test or χ2 tests for trend for categorical variables. 2-sided p-values are reported.